New kits incorporate Quansys' M.E.™ technology
for assays that are central to kinase drug discovery programs
- Quansys Biosciences™ and LI-COR® Biosciences announce the
introduction of four kits for infrared (IR) multiplexed Enzyme Linked
Immonosorbant Assay (ELISA) arrays. These assays are central to kinase
drug discovery programs for indications including oncology, inflammation,
metabolic, cardiovascular and neurological diseases. The kits include
Quansys Multiplexed ELISA™ (Quansys M.E.™) Human Cytokine
- IR (9-plex), Human Chemokine - IR (9-plex), Mouse Cytokine - IR (9-plex),
and Mouse Chemokine - IR (9-plex).
Quansys Multiplexed ELISA IR arrays are fully quantitative multiplex
ELISA-based tests where 9 distinct capture antibodies have been absorbed
to each well of a 96-well plate in a defined array. Using less than 30
microliters of sample, up to 80 samples can be assayed for all 9 in less
than two and a half hours, allowing for considerable savings of time,
sample and money. The new kits are designed for use on LI-COR Odyssey®
and Aerius® infrared imaging systems.
"We are dedicated to the development of protein arrays to aide
researchers and clinicians in better understanding, diagnosing and treating
disease for the betterment of people's lives," said Matt Groll,
vice president of product development for Quansys. "It is our hope
that the tools we develop will allow researchers to better serve humanity."
"The integration of the Quansys ELISA assay platform with the infrared
detection capabilities of the Odyssey and Aerius imaging systems will
deliver improved quantitation accuracy and superior data reproducibility
for plate based protein arrays," says Jim Wiley, LI-COR product
marketing manager.
Quansys Biosciences, a Spendlove Research Medical Institute (SMRI) company,
is dedicated to the development of multiplexed protein arrays to aide
researchers and clinicians in better understanding, diagnosing and treating
disease. Quansys Biosciences is located in beautiful Cache Valley near
Utah State University in Logan, Utah. The SMRI was founded in 1989 and
is funded through an endowment established by Dr. Rex S. and Reta Spendlove
and family. Dr. Spendlove is the founder of Hyclone Laboratories, a leading
producer and distributor of cell culture media throughout the world. Quansys
donates a portion of its revenues back to the Institute in an effort to
help fund further scientific research that will have a positive impact
on human life. Further information can be obtained at www.quansysbio.com
LI-COR Biosciences is a leader in the design and manufacture of instrument
systems for biotechnology, plant biology and environmental research. The
company pioneered the development of infrared fluorescence labeling and
detection systems for proteomics, DNA sequencing, microsatellites and
AFLP® research. The Odyssey Infrared Imaging System is rapidly becoming
the system of choice for quantitative Western Blot analysis. Frost &
Sullivan named the Odyssey System the 2006 North American Drug Discovery
Technologies Product of the Year.
Founded in 1971, the privately held company is based in Lincoln, Nebraska,
with subsidiaries in Germany and the United Kingdom. LI-COR systems are
used in more than 100 countries and are supported by a global network
of distributors. Further information can be obtained at www.licor.com.
D. Doc Chaves, LI-COR Biosciences, dchaves@licor.com,
402-467-0750
Christian Iverson, Quansys Biosciences, civerson@quansysbio.com,
435-752-0531
|
